Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (258) clinical trials

The primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) score as compared with placebo in participants with early AD. Secondary objectives are to assess the ...

Phase

To test the idea that solanezumab will slow the cognitive and functional decline of Alzheimer's Disease (AD) as compared with placebo in participants with mild AD.

Phase

The purpose of this study is to evaluate the effect of pioglitazone at 24 months compared with placebo on cognitive decline in high-risk participants who have completed the AD-4833/TOMM40_301 study [NCT01931566] with an adjudicated diagnosis of mild cognitive impairment (MCI) due to Alzheimer's Disease (AD).

Phase

The purpose of this study is to provide subjects who have completed participation in a Phase 2 or Phase 3 trial with TRx0237 continued access to therapy and to evaluate the long-term safety of TRx0237.

Phase

To establish efficacy of Lu AE58054 as adjunctive therapy to acetylcholinesterase inhibitors (AChEIs) for symptomatic treatment of patients with mild-moderate Alzheimer's disease (AD).

Phase

A serial mild cognitive impairment (MCI) and Alzheimer's disease study with longitudinal measurement of cognition and biomarkers such as DNA/RNA/SERUM PLASMA/CSF

Phase N/A

The primary objectives of this study are to assess the effects of RVT-101 versus placebo as adjuncts to stable donepezil therapy on cognitive function as measured by the Alzheimer’s Disease Assessment Scale - Cognitive Subscale 11 items (ADAS-Cog-11) after 24 weeks of treatment AND on activities of daily living as ...

Phase

A Research Study is being conducted to evaluate an oral investigational medication that may help slow down the progression of what could be very early Alzheimer’s disease. Prodromal Alzheimer’s disease is the very early stage of the disease when minor symptoms first appear. A diagnosis can only be confirmed through ...

Phase N/A

A Research Study is being conducted to evaluate an oral investigational medication that may help slow down the progression of what could be very early Alzheimer’s disease. Prodromal Alzheimer’s disease is the very early stage of the disease when minor symptoms first appear. A diagnosis can only be confirmed through ...

Phase N/A

The ENGAGE Study is a global study assessing the efficacy and safety of an investigational medication, to determine whether it can slow the progression of symptoms in early Alzheimer’s disease. There is an important medical and scientific need to research therapies that could delay memory loss and the progression of ...

Phase